Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the detailed record of transactions filed by Benzeno Sharon, Directeur du Développement Commercial. Insider active across 1 company, notably Adaptive Biotechnologies Corp. Cumulatively, 11 filings have been logged. Split: 0 buy · 2 sells. History available since 4 March 2022. The latest transaction was disclosed on 4 March 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations
Sharon Benzeno is the Chief Business Development Officer at Adaptive Biotechnologies Corp. She is responsible for developing and executing the company's business development strategies. Sharon plays a key role in identifying new market opportunities and expanding Adaptive's operations.